Biohaven Acute Migraine Study

Description:

This study is dedicated to evaluating the effectiveness of a medication that treats acute migraine attacks in participants 18+ years of age. The duration of this study is 24 weeks in total and consists of 8 study appointments during that time.  

Qualified Participants are: 

  • Experience on average of 4-14 migraine attacks a month 

Location:

6210 Brandt Pike, Suite 102

Dayton, Ohio 45424

(937) 912-4369

Chronic Migraine Study - Dayton

WellNow Urgent Care & Research partners with multinational pharmaceuticals, biotechnology companies, medical device manufacturers & CROs to help drive improvements to health and well-being. In our 15 years of research, WellNow has had over 17,000 visits to our network of clinical research sites.
Facebook for WellNow Urgent Care
Youtube for WN research
Twitter for WN Research

© 2022 WELLNOW URGENT CARE & RESEARCH